Skip to main content
. 2023 Jul 18;15(7):1973. doi: 10.3390/pharmaceutics15071973

Figure 8.

Figure 8

Antidiabetic activity study in diabetic rats after administration of Ins-PO (50 IU/kg), Ins-SDS (50 IU/kg), optimized SMEDDS (50 IU/kg), and Ins-SC (5 IU/kg).